Can low dietary protein intake lower albumin and globulin?

Dietary protein restriction limits systemic and portal amino acid availability, compromising the vital substrates required for the synthesis of major circulating proteins.

Hepatic albumin suppression

• Translational inhibition: Reduced amino acid levels activate the hepatic GCN2-eIF2α stress pathway. Phosphorylation of eIF2α directly halts global translation initiation, while concurrent downregulation of mTOR signaling suppresses the translation of highly abundant plasma proteins.
• Systemic decline: Because albumin is synthesized exclusively in the liver, these molecular blocks reduce the albumin fractional synthetic rate (FSR) by 20% to 65% in humans. Over time, this translational arrest exhausts compensatory mechanisms—such as mobilizing extravascular albumin pools and slowing catabolism—culminating in overt hypoalbuminemia.

Immune protein and globulin reduction

• Impaired immune translation: Deficiencies in critical amino acid substrates (particularly lysine, arginine, and branched-chain amino acids) restrict lymphocyte proliferation, blunt B-cell development, and limit cytokine production.
• Circulating globulin depletion: Because immunoglobulins are rapidly synthesized by active immune cells, substrate depletion limits antibody generation. This translational bottleneck directly reduces circulating globulins, resulting in clinical hypoglobulinemia (depleted total gamma-globulins and IgG) and compromised humoral immunity.

Bottom line

• Low dietary protein intake lowers circulating albumin and globulin levels by depleting amino acid substrates, triggering GCN2-eIF2α-mediated translational arrest, suppressing mTOR signaling in hepatocytes, and blunting active humoral antibody synthesis.